First Choice Healthcare Details $21.3M Acquisition of Pointe Medical and Live Well Drugstore
FCHS has more than doubled off its 52-week low of $0.002 on light trading volume (0.3× avg).
Summary
First Choice Healthcare Solutions filed an 8-K detailing its $21.3 million acquisition of four healthcare entities, contingent on its pending SPAC merger and a $100 million equity line. The deal includes $10 million in cash, $4.3 million in assumed debt, and $6 million in stock.
Key Events · M&A and Partnerships · FCHS
-
Acquisition Agreement Signed
First Choice Healthcare entered into an Amended and Restated Stock Purchase Agreement to acquire Pointe Medical Services, Pointe Med Pharmacy, Livewell MD, and Live Well Drugstore for a maximum purchase price of $21,306,000.
-
Purchase Price Breakdown
The purchase price includes $7.0 million in closing cash (reduced by $300K in advances already paid), $3.0 million in deferred cash, $4.306 million in assumed indebtedness, $6.0 million in PubCo common stock, and a $1.0 million contingent performance bonus.
-
Contingent on SPAC Merger
The acquisition closing is conditioned upon the consummation of the Business Combination with Westin Acquisition Corp., effectiveness of the Form F-4 registration statement, and availability of the ELOC Facility of up to $100 million.
-
Financing Risk
The company has a near-zero cash balance and a going concern warning, making the availability of the ELOC Facility and the SPAC merger critical to completing this acquisition.
Analysis · FCHS · Industrial Applications And Services
First Choice Healthcare Solutions disclosed the full terms of its Amended and Restated Stock Purchase Agreement to acquire Pointe Medical Services, Pointe Med Pharmacy, Livewell MD, and Live Well Drugstore for up to $21.3 million. The deal is contingent on the previously announced SPAC merger with Westin Acquisition Corp. and the availability of a $100 million equity line of credit. Given the company's near-zero cash balance and going concern warning, this acquisition is a critical step in its survival strategy, but it also adds significant execution risk and potential dilution through the issuance of $6 million in PubCo stock.
At the time of this filing, FCHS was trading at $0.01 on OTC in the Industrial Applications And Services sector, with a market capitalization of approximately $306.5K. The 52-week trading range was $0.00 to $0.51. This filing was assessed with neutral market sentiment and an importance score of 8 out of 10.